BioSpace News Archive

Rezolute, Inc., a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, announced that Nevan Charles Elam, CEO and Founder, will present at two upcoming virtual investment conferences.

Chimerix, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced that Mike Sherman, Chief Executive Officer, will participate in a panel discussion at the 2021 Wedbush PacGrow Healthcare Conference on Tuesday, August 10, 2021 at 10:55 a.m. ET.

iTeos Therapeutics, Inc. announced that Michel Detheux, PhD, President and Chief Executive Officer, will present at the upcoming Wedbush PacGrow Healthcare Conference 2021 on Tuesday, August 10, 2021 at 2:20 p.m. ET.

Rhythm Pharmaceuticals, Inc., a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, reported financial results and provided a business update for the second quarter ended June 30, 2021.

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter financial results and provide a business update on Wednesday, August 11, 2021.

Bio-Techne Corporation announced that management will host its 2021 Investor Day on Friday, September 10, 2021, starting at 9:00 a.m. EDT.

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, announced the appointment of Kathy LaPorte to its Board of Directors.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that Richard Paulson, President and Chief Executive Officer, will participate on a speaker panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference titled, “Building Back a Better Commercial Infrastructure – Selling in COVID Times” and participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference.

Ginkgo Bioworks, Inc. announced that Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President at Vertex, will join its board of directors.

PYC Therapeutics, a biotechnology company combining two complementary platform technologies to develop a new generation of RNA therapeutics to change the lives of patients with inherited diseases, announced that members of the management team will participate in the following healthcare investor conferences: